5GZ0
Crystal structure of FM329, a recombinant Fab adopted from cetuximab
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | PAL/PLS BEAMLINE 5C (4A) |
Synchrotron site | PAL/PLS |
Beamline | 5C (4A) |
Temperature [K] | 100 |
Detector technology | AREA DETECTOR |
Collection date | 2016-02-23 |
Detector | ADSC QUANTUM 315r |
Wavelength(s) | 1.0000 |
Spacegroup name | P 1 21 1 |
Unit cell lengths | 72.521, 68.031, 97.780 |
Unit cell angles | 90.00, 101.84, 90.00 |
Refinement procedure
Resolution | 47.850 - 1.700 |
R-factor | 0.1885 |
Rwork | 0.188 |
R-free | 0.22650 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 1yy8 |
RMSD bond length | 0.010 |
RMSD bond angle | 1.082 |
Refinement software | PHENIX ((1.10.1_2155)) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 49.110 | 1.730 |
High resolution limit [Å] | 1.690 | 1.700 |
Number of reflections | 101903 | |
<I/σ(I)> | 28.08 | 3.14 |
Completeness [%] | 99.6 | 99.1 |
Redundancy | 4.1 | 4.1 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 8 | 290 | 20% (w/v) PEG 3000, 100 mM Imidazole, Hydrochloric acid pH 8.0, 200 mM Zinc acetate |